当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Joshua L Bonkowsky
Neuroepidemiology is a translational science based on the use of epidemiologic data in the domain of neurological and psychiatric diseases. The epidemiological data have the goal of understanding the causes of disease collecting information on new cases of disease (incidence) and evaluating the consequence of disease using information on new and old cases (prevalence) estimating the burden of disease. The unifying concept in epidemiology is the construction of appropriate analytic methods to elaborate heterogeneous and complex data with construction of the proper study design, techniques to estimate the links between causes of diseases and disease onset and frequencies, taking into account possible factors that may distort or induce changes in the estimates (confounding and interaction). In this article, we analyze the pros and cons of all the main study designs to determine frequencies, association and causes of disease: cohort studies, case-control, prognostic studies and randomized clinical trials. We analyze also a particular study design as the case cross-over study.